Open AccessDiagnostic accuracy of prostate-specific antigen below 4 ng/mL as a cutoff for diagnosing prostate cancer in a hospital setting: A systematic review and meta-analysis
Author(s) -
Yan Jin,
Jae Hung Jung,
Woong Kyu Han,
Eu Chang Hwang,
Yoonmi Nho,
Na-Rae Lee,
Ji Eun Yun,
Kwang Suk Lee,
Sang Hyub Lee,
Hakmin Lee,
Su-Yeon Yu
Publication year - 2022
Publication title -
investigative and clinical urology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.653
H-Index - 14
eISSN - 2466-054X
pISSN - 2466-0493
DOI - 10.4111/icu.20210429
Subject(s) - medicine , cutoff , prostate cancer , diagnostic odds ratio , meta analysis , prostate specific antigen , receiver operating characteristic , likelihood ratios in diagnostic testing , urology , odds ratio , prostate , cancer , gynecology , oncology , physics , quantum mechanics
A prostate-specific antigen (PSA) cutoff of 4 ng/mL has been widely used for prostate cancer screening in population-based settings. However, the accuracy of PSA below 4 ng/mL as a cutoff for diagnosing prostate cancer in a hospital setting is inconclusive. We systematically reviewed the accuracy of PSA below 4 ng/mL cutoff in a hospital setting.